Breaking News

PCI Pharma Services Passes ICMRA’s Collaborative Hybrid Inspection Pilot

Becomes the first drug product CDMO to navigate the multi-agency inspection process.

Author Image

By: Charlie Sternberg

Associate Editor

PCI Pharma Services (PCI), a global contract development and manufacturing organization (CDMO), has successfully completed the International Coalition of Medicines Regulatory Authorities (ICMRA) inspection of its Bedford, New Hampshire campus.   In doing so, PCI becomes the first drug product CDMO to navigate the multi-agency inspection process, a facet of the ICMRA’s new Collaborative Hybrid Inspection Pilot (CHIP) program, which is focused on the mutual assessment of facilities that manufact...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters